source
- Bristol Myers revises Phase 3 fibrosis trial after liver safety events, including a deathBristol Myers Squibb announced a change to its late-stage Phase 3 "Aloft" trial of the experimental pulmonary fibrosis drug admilparant. The amendment adds closer monitoring for liver-related adve…
- FDA begins review of Roche’s experimental multiple sclerosis pill fenebrutinibThe FDA has accepted Roche's application for fenebrutinib, an experimental oral therapy for multiple sclerosis, and has started a priority review. The review will evaluate the drug in both relapsi…